Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets (Unaudited)

 v2.3.0.11
Balance Sheets (Unaudited) (USD $)
Jun. 30, 2011
Dec. 31, 2010
Current Assets:    
Cash and cash equivalents $ 89,000 $ 54,000
Prepaid expenses 105,000 83,000
Total Current Assets 194,000 137,000
Patents, net 34,000 48,000
Total Other Assets 34,000 48,000
TOTAL ASSETS 228,000 185,000
Current Liabilities:    
Accounts payable 772,000 625,000
Accrued interest 1,560,000 1,439,000
Accrued expenses 392,000 414,000
Warrant liability 980,000 1,012,000
Demand notes payable, net of discount of $84,000 and $0 227,000 205,000
Convertible debentures, net of discount of $32,000 and $250,000, current portion 668,000 415,000
Convertible debentures 1,199,000 1,544,000
Total Current Liabilities 5,798,000 5,654,000
Stockholders' Deficit:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: Series C - 96,230 and 96,230 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively 1,000 1,000
Series H - 25,000 and 25,000 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively 0 0
Series I - 1,666,667 and 1,666,667 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively 2,000 2,000
Common stock - $0.001 par value; 600,000,000 shares authorized; 209,499,515 and 149,571,976 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively 209,000 149,000
Additional paid-in capital 76,898,000 74,474,000
Accumulated deficit (82,680,000) (80,095,000)
Total Stockholders' Deficit (5,570,000) (5,469,000)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 228,000 $ 185,000